Neoprobe Corporation markets its gamma detection systems, detector probes and accessories worldwide for surgical procedures called Intraoperative Lymphatic Mapping (ILM) or sentinel lymph node biopsy, a minimally invasive technique for evaluating the potential spread of cancer to lymph node tissues and organs.
A CZT Sensor is coupled with an electronics package intended to detect and quantify gamma radiation.
Neoprobe is the only company developing both gamma detection systems and radio tracers.
This combination of technologies represents a first in the health care field and offers a unique ability to optimize the radio tracers and gamma detection system.
Featured equipment: Neoprobe's Model 1100 Bluetooth Probes (top) Model 1017 Reusable Detector Probe (middle) Model 2059 Reusable Detector Probe (bottom).